Declan Doogan - Net Worth and Insider Trading
Declan Doogan Net Worth
The estimated net worth of Declan Doogan is at least $21 Million dollars as of 2024-11-13. Declan Doogan is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $21 Million. Details can be seen in Declan Doogan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Declan Doogan has not made any transactions after 2021-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Declan Doogan
Declan Doogan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Declan Doogan owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Tenax Therapeutics Inc (TENX) .
Click here to see the complete history of Declan Doogan’s form 4 insider trades.
Insider Ownership Summary of Declan Doogan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-11-29 | director |
TENX | Tenax Therapeutics Inc | 2021-02-25 | director |
Declan Doogan Latest Holdings Summary
Declan Doogan currently owns a total of 1 stock. Declan Doogan owns 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 29, 2021, with a value of $21 Million.
Latest Holdings of Declan Doogan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-11-29 | 1,496,650 | 14.08 | 21,072,832 |
Holding Weightings of Declan Doogan
Declan Doogan Form 4 Trading Tracker
According to the SEC Form 4 filings, Declan Doogan has made a total of 6 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 24,525 shares on November 29, 2021, which brought Declan Doogan around $3 Million.
Insider Trading History of Declan Doogan
- 1
Declan Doogan Trading Performance
Declan Doogan Ownership Network
Ownership Network List of Declan Doogan
Ownership Network Relation of Declan Doogan
Declan Doogan Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Declan Doogan is the director of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Declan Doogan Mailing Address
Above is the net worth, insider trading, and ownership report for Declan Doogan. You might contact Declan Doogan via mailing address: C/o Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven Ct 06510.